TMCnet News
Scanadu Packs More Features Into Scanadu Scout™; Unveils Design For ScanaFlo™MOUNTAIN VIEW, Calif. --(Business Wire)-- NASA Ames Research Park, Moffett Field -- Scanadu, a personalized health electronics company participating in the Qualcomm Tricorder X PRIZE, today announced it is one step closer to bringing the first medical tricorder™ to life. In addition to unveiling updates and refinements to Scanadu Scout™ and ScanaFlo™, the company has also launched an Indiegogo campaign, inviting supporters to reserve a first-edition Scanadu Scout™ and contribute to building the future global body of health data. "We are in awe at the enthusiasm the community has shown for the Scanadu Scout since the prototype was first revealed six months ago. We get calls and emails everyday from parents, researchers, students and body hackers anxious to be part of the first generation of consumers to truly understand their own health," said Scanadu Founder and CEO Walter de Brouwer. "We've pushed the envelope, had some key breakthroughs, and are ready to share this next iteration of the product with consumers." Scanadu Scout is a vital sign monitor that analyzes, tracks, and trends your vitals - temperature, respiratory rate, oximetry, ECG, systolic blood pressure, diastolic blood pressure, and stress - in 10 seconds. With encouraging feedback from the community, partners, and regulators, and a strong push from Scanadu's engineers and researchers, the company has made three key breakthroughs:
Scanadu has received its first batch of 6,000 paddles and is ready to begin clinical trials. The company anticipates submitting a 510(k) application to FDA in the beginning of July 2013. "Today's urine tests are really hard to use and the results are not easy to interpret," said Aaron Rowe, research director at Scanadu. "ScanaFlo will make it simple for pregnant women to monitor themselves for complications between appointments with their doctor." Lastly, starting today, supporters can reserve a first-edition Scanadu Scout on Indiegogo and be part of the exploratory community bringing to life the vision of making this the last generation to know so little about our health. As a participant in the Indiegogo campaign, supporters will be able to take part in a usability study and provide feedback on feasibility, usability, and consumer friendliness that will be a valuable part of Scanadu's road to FDA. The 30-day campaign will offer a variety of perks including regular updates from Scanadu, a limited edition Scanadu Scout, visits to NASA to spend the day as a citizen astronaut for a space medicine workshop, and a tour of NASA Ames Research Park. Scanadu will offer an early bird special of $149 for the device to the first 1,000 participants. Additional units will be made available at the anticipated retail price of $199. Additionally, two ScanaFlo paddles be included with each Scanadu Scout, which is expected to ship in Q1 2014. The devices on Indiegogo are not FDA approved. STAR (News - Alert) TREK, TRICORDER and related marks and logos are trademarks of CBS Studios Inc. used under license by the X PRIZE Foundation. Scanadu is a participant in the Qualcomm (News - Alert) Tricorder X PRIZE competition. About Scanadu Based at NASA-Ames Research Park, Scanadu is using mobile, sensor and social technology to ensure this is the last generation to know so little about our health. In November 2012, the company unveiled its product family consisting of the Scanadu Scout™ vital sign monitor, ScanaFlo™ urine analysis test and ScanaFlu saliva test. The first products look to disrupt home medicine and will be in market early 2014. Scanadu was founded by Walter de Brouwer in 2010 and is competing in the Qualcomm Tricorder X Prize. For more information visit www.Scanadu.com.
|
